Cullinan Therapeutics Inc 2026年季度报告

(Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the quarterly period ended March 31, 2026OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 FOR THE TRANSITION PERIOD FROMTO CULLINAN THERAPEUTICS, INC. (Exact name of Registrant as specified in its Charter) (617) 410-4650 (Registrant’s telephone number, including area code) Not Applicable (Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file suchreports), and (2) has been subject to such filing requirements for the past 90 days. YES☒NO☐ Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period thatthe Registrant was required to submit such files). YES☒NO☐ Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated filer☐Smaller reporting company☒Emerging growth company☐ Large accelerated filer☐Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES☐NO☒ The number of shares of the Registrant’s common stock outstanding as of April 30, 2026 was 61,458,046. Table of Contents PART I.FINANCIAL INFORMATION Item 1.Financial Statements (unaudited)1Consolidated Balance Sheets1Consolidated Statements of Operations and Comprehensive Income (Loss)2Consolidated Statements of Stockholders’ Equity3Consolidated Statements of Cash Flows4Notes to the Consolidated Financial Statements5Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations12Item 3.Quantitative and Qualitative Disclosures About Market Risk18Item 4.Controls and Procedures18 PART II.OTHER INFORMATION Item 1.Legal ProceedingsItem 1A.Risk FactorsItem 2.Unregistered Sales of Equity Securities and Use of ProceedsItem 3.Defaults Upon Senior SecuritiesItem 4.Mine Safety DisclosuresItem 5.Other InformationItem 6.ExhibitsSignatures 1919191919192021 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements which are made pursuant to the safe harborprovisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, asamended, that involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, orachievements to be materially different from the information expressed or implied by these forward-looking statements. Allstatements, other than statements of historical facts, contained in this Quarterly Report on Form 10-Q, including statementsregarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and objectivesof management, and expected market growth are forward-looking statements. The words “anticipate,” “believe,” “continue,”“could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “would”, and similarexpressions are intended to identify forward-looking statements, although not all forward-looking statements contain theseidentifying words. Any forward-looking statements in this Quarterly Report on Form 10-Q reflect our current views with respect to future eventsor to our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause ouractual results, performance or achievements to be materially different from any future results, performance or achievementsexpressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from currentexpectations include, among other things, those listed in our Annual Report on Form 10-K for the year ended December 31, 2025(the "2025 10-K") and other filings with the Securities and Exchange Commission (the “SEC”), including the following: ii•the commercial success, cost of development, and timing of the approva